Assignee
INTERMUNE INC
US·40 granted patents·65 pending applications·517 citations·filing 1983–2019
Top patents by PatentIndex Score
105 records- 0198US7491794B2Macrocyclic compounds as inhibitors of viral replicationINTERMUNE INC·Filed 2005·Granted Feb 17, 2009·147 cites·1 claims
- 0296US7816383B1Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2010·Granted Oct 19, 2010·27 cites·20 claims
- 0396US7728013B2Method of modulating stress-activated protein kinase systemINTERMUNE INC·Filed 2006·Granted Jun 1, 2010·40 cites·19 claims
- 0496US7696236B2Method of providing pirfenidone therapy to a patientINTERMUNE INC·Filed 2009·Granted Apr 13, 2010·32 cites·7 claims
- 0595US7767700B2Method of providing pirfenidone therapy to a patientINTERMUNE INC·Filed 2007·Granted Aug 3, 2010·26 cites·19 claims
- 0694US7566729B1Modifying pirfenidone treatment for patients with atypical liver functionINTERMUNE INC·Filed 2009·Granted Jul 28, 2009·37 cites·9 claims
- 0793US7829665B2Macrocyclic inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2006·Granted Nov 9, 2010·27 cites·29 claims
- 0893US7635707B1Pirfenidone treatment for patients with atypical liver functionINTERMUNE INC·Filed 2009·Granted Dec 22, 2009·15 cites·14 claims
- 0991US8013002B2Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2011·Granted Sep 6, 2011·9 cites·11 claims
- 1091US7910610B1Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2010·Granted Mar 22, 2011·10 cites·11 claims
- 1190US9675593B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2016·Granted Jun 13, 2017·10 cites·24 claims
- 1290US7767225B2Capsule formulation of pirfenidone and pharmaceutically acceptable excipientsINTERMUNE INC·Filed 2009·Granted Aug 3, 2010·11 cites·20 claims
- 1389US9359379B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2013·Granted Jun 7, 2016·12 cites·21 claims
- 1489US8383150B2Granulate formulation of pirfenidone and pharmaceutically acceptable excipientsINTERMUNE INC·Filed 2011·Granted Feb 26, 2013·9 cites·27 claims
- 1589US7988994B2Capsule formulation of pirfenidone and pharmaceutically acceptable excipientsINTERMUNE INC·Filed 2006·Granted Aug 2, 2011·10 cites·28 claims
- 1688US8969347B2Compounds and methods for treating inflammatory and fibrotic disordersINTERMUNE INC·Filed 2012·Granted Mar 3, 2015·10 cites·22 claims
- 1788US7407973B2Use of pirfenidone in therapeutic regimensINTERMUNE INC·Filed 2004·Granted Aug 5, 2008·36 cites·18 claims
- 1887US7638488B2Use of alpha-glucosidase inhibitors to treat alphavirus infectionsINTERMUNE INC·Filed 2006·Granted Dec 29, 2009·3 cites·20 claims
- 1986US10376497B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2017·Granted Aug 13, 2019·5 cites·37 claims
- 2085US8778947B2Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2013·Granted Jul 15, 2014·5 cites·18 claims
- 2185US7781474B2Inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2007·Granted Aug 24, 2010·7 cites·13 claims
- 2283US9290450B2Compounds and methods for treating inflammatory and fibrotic disordersINTERMUNE INC·Filed 2014·Granted Mar 22, 2016·5 cites·27 claims
- 2383US8753679B2Capsule formulation of pirfenidone and pharmaceutically acceptable excipientsINTERMUNE INC·Filed 2013·Granted Jun 17, 2014·4 cites·26 claims
- 2482US10233195B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2015·Granted Mar 19, 2019·4 cites·31 claims
- 2582US7932267B2Use of α-glucosidase inhibitors to treat alphavirus infectionsINTERMUNE INC·Filed 2009·Granted Apr 26, 2011·1 cites·15 claims
- 2681US9561217B2Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridoneINTERMUNE INC·Filed 2015·Granted Feb 7, 2017·2 cites·20 claims
- 2780US10898474B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2019·Granted Jan 26, 2021·1 cites·63 claims
- 2878US8048862B2Macrocyclic inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2009·Granted Nov 1, 2011·3 cites·40 claims
- 2977US9017722B2Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridoneINTERMUNE INC·Filed 2012·Granted Apr 28, 2015·2 cites·14 claims
- 3075US7932277B2Peptide inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2008·Granted Apr 26, 2011·2 cites·79 claims
- 3174US9527816B2Method of modulating stress-activated protein kinase systemINTERMUNE INC·Filed 2014·Granted Dec 27, 2016·1 cites·24 claims
- 3273US2020038387A1Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2019·Application pending·0 cites
- 3371US2019183872A1Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2019·Application pending·0 cites
- 3470US2020113884A1Method of providing pirfenidone therapy to a patientINTERMUNE INC·Filed 2019·Application pending·0 cites
- 3570US2019247380A1Method of providing pirfenidone therapy to a patientINTERMUNE INC·Filed 2019·Application pending·0 cites
- 3670US2018311221A1Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2018·Application pending·0 cites
- 3769US2019060299A1Pirfenidone Treatment for Patients with Atypical Liver FunctionINTERMUNE INC·Filed 2018·Application pending·0 cites
- 3868US2019000821A1Method of providing pirfenidone therapy to a patientINTERMUNE INC·Filed 2018·Application pending·0 cites
- 3968US2014350060A1Methods of Administering Pirfenidone TherapyINTERMUNE INC·Filed 2014·Application pending·0 cites
- 4068US2018064695A1Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2017·Application pending·0 cites
- 4167US2018140588A1Method of Providing Pirfenidone Therapy to a PatientINTERMUNE INC·Filed 2018·Application pending·0 cites
- 4267US2018200242A1Pirfenidone Treatment for Patients with Atypical Liver FunctionINTERMUNE INC·Filed 2018·Application pending·0 cites
- 4366US2017128429A1Methods of Administering Pirfenidone TherapyINTERMUNE INC·Filed 2017·Application pending·0 cites
- 4465US2015111899A1Pirfenidone therapy and inducers of cytochrome p450INTERMUNE INC·Filed 2014·Application pending·0 cites
- 4565US2017333411A1Pirfenidone treatment for patients with atypical liver functionINTERMUNE INC·Filed 2017·Application pending·0 cites
- 4665US2014073673A1Pirfenidone Treatment for Patients with Atypical Liver FunctionINTERMUNE INC·Filed 2013·Application pending·0 cites
- 4764US2016303098A1Methods of Administering Pirfenidone TherapyINTERMUNE INC·Filed 2016·Application pending·0 cites
- 4864US2013220871A1Method of providing pirfenidone therapy to a patientINTERMUNE INC·Filed 2013·Application pending·0 cites
- 4963US10010536B2Method of modulating stress-activated protein kinase systemINTERMUNE INC·Filed 2016·Granted Jul 3, 2018·0 cites·4 claims
- 5063USRE39821EManufacture and expression of large structural genesINTERMUNE INC·Filed 2005·Granted Sep 4, 2007·0 cites·3 claims
Showing the top 50 of 105 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when INTERMUNE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →